Please login or sign up to post and edit reviews.
023 – Jeff June
Publisher |
Loup Ventures
Media Type |
audio
Categories Via RSS |
Tech News
Technology
Publication Date |
Aug 27, 2019
Episode Duration |
00:31:46
Jeff June is the founder and CEO of IschemiaCare. Jeff comes from a background in venture capital and private equity, and held the Forsythe Chair in Entrepreneurship at Miami University of Ohio. Top 3 Takeaways In 40% of stroke cases, the specific...
Jeff June is the founder and CEO of IschemiaCare. Jeff comes from a background in venture capital and private equity, and held the Forsythe Chair in Entrepreneurship at Miami University of Ohio. Top 3 Takeaways In 40% of stroke cases, the specific cause is unknown. * Stroke care can benefit from greater diagnostic personalization. * Having the right people in your life and on your team is an outsized advantage. Show Notes * [1:00] Jeff’s background. * [2:45] Origin of IschemiaCare. * [5:52] What IschemiaCare does. * [8:05] A-fib stroke. * [10:20] How IschemiaCare gains usage. * [13:30] IschemiaCare’s business model. * [15:20] Growth plan. * [16:00] IschemiaCare’s product and how it fits into stroke care pipeline. * [17:50] The RNA data play. * [19:40] Extrapolating data insights. * [23:40] Key lessons about healthtech. * [27:30] Reminding people of your mission. * [30:00] Doug’s meme on the Loup website. Selected Links * IschemiaCare * Stroke care guidelines Related Podcasts * 020 – Mary Beth Henderson * 017 – Ana Maiques * 013 – Ladan Jiracek, Manfred Franke, and Doug Clinton Disclaimer

Jeff June is the founder and CEO of IschemiaCare. Jeff comes from a background in venture capital and private equity, and held the Forsythe Chair in Entrepreneurship at Miami University of Ohio.

Top 3 Takeaways

  1. In 40% of stroke cases, the specific cause is unknown.
  2. Stroke care can benefit from greater diagnostic personalization.
  3. Having the right people in your life and on your team is an outsized advantage.

Show Notes

  • [1:00] Jeff’s background.
  • [2:45] Origin of IschemiaCare.
  • [5:52] What IschemiaCare does.
  • [8:05] A-fib stroke.
  • [10:20] How IschemiaCare gains usage.
  • [13:30] IschemiaCare’s business model.
  • [15:20] Growth plan.
  • [16:00] IschemiaCare’s product and how it fits into stroke care pipeline.
  • [17:50] The RNA data play.
  • [19:40] Extrapolating data insights.
  • [23:40] Key lessons about healthtech.
  • [27:30] Reminding people of your mission.
  • [30:00] Doug’s meme on the Loup website.

Selected Links

Related Podcasts

Disclaimer

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review